Ellipsis Neurotherapeutics, Transition Therapeutics deal

TTH acquired a 17% stake in Ellipsis in exchange for about C$2 million (US$1.7 million), which includes C$1 million in cash plus 884,956 TTH shares. The shares are valued at C$991,150 based on TTH's N...